Skip to search formSkip to main contentSkip to account menu

23-valent pneumococcal capsular polysaccharide vaccine

Known as: 23-valent vaccine, pneumococcal polysaccharide PPV23, PCV 23 
National Institutes of Health

Related topics

Related topics

5 relations
Merck and Co., Inc.Polyvalent pneumococcal vaccine

Narrower (2)

Pneumo-23Pneumovax 23

Broader (1)

Pneumococcal vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan
Abstract Older adults, particularly those with chronic obstructive pulmonary disease, are advised to receive 23-valent… 
2017
2017
Amélioration de la couverture vaccinale antipneumococcique chez les patients pris en charge pour une maladie systémique grâce à un programme de vaccination mené par les infirmières
2016
2016
Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine
ABSTRACT Introduction: Diseases caused by Streptococcus pneumoniae are a major public health problem worldwide, which can be… 
Review
2015
Review
2015
Dosing regimen of the 23-valent pneumococcal vaccination: a systematic review.
2014
2014
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine
The current study examined the safety and immunogenicity of 23-valent pneumococcal capsular polysaccharide vaccine (Pneumo23… 
Review
2012
Review
2012
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?
Purpose of review Pneumococcal glycoconjugate vaccines (PCVs) are now widely used in infant immunization schedules. These… 
Review
2012
Review
2012
Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
For the influenza pandemic of 2009-2010, countries responded to the direct threat of influenza but may have missed opportunities… 
Highly Cited
2010
Highly Cited
2010
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old
This study evaluated safety & immunogenicity of ZOSTAVAX® (zoster vaccine: ZV) administered concomitantly versus nonconcomitantly… 
2008
2008
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)